+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Low-dose dobutamine echo stress test for the evaluation of cardiac function in asymptomatic childhood cancer survivors treated years before with anthracycline



Low-dose dobutamine echo stress test for the evaluation of cardiac function in asymptomatic childhood cancer survivors treated years before with anthracycline



European Heart Journal 19(ABST SUPPL ): 312




(PDF emailed within 1 workday: $29.90)

Accession: 032205789

Download citation: RISBibTeXText


Related references

Evaluation of cardiac reserved function by high-dose dobutamine-stress echocardiography in asymptomatic anthracycline-treated survivors of childhood cancer. Pediatrics International 48(3): 313-320, 2006

Low-dose dobutamine stress echocardiography in asymptomatic doxorubicin-treated long-term survivors of childhood cancer. European Heart Journal 22(Abstract Supplement): 540, 2001

The role of dobutamine stress echocardiography in early diagnosis of cardiac toxicity in long-term survivors of asymptomatic children treated with anthracycline. Anadolu Kardiyoloji Dergisi 10(2): 154-162, 2010

Dobutamine stress echocardiography: a sensitive indicator of diminished myocardial function in asymptomatic doxorubicin-treated long-term survivors of childhood cancer. Journal of the American College of Cardiology 19(2): 394-401, 1992

Dobutamine stress echocardiography in the evaluation of late anthracycline cardiotoxicity in childhood cancer survivors. Pediatric Research 39(3): 504-512, 1996

Dobutamine stress test in long term childhood cancer survivors treated with doxorubicin. Journal of the American College of Cardiology 17(2 SUPPL A): 333A, 1991

Low-dose dobutamine test associated with interventricular dyssynchrony: a useful tool to identify cardiac resynchronization therapy responders: data from the LOw dose DObutamine stress-echo test in Cardiac Resynchronization Therapy (LODO-CRT) phase 2 study. American Heart Journal 163(3): 422-429, 2012

Evaluation of traditional and novel measures of cardiac function to detect anthracycline-induced cardiotoxicity in survivors of childhood cancer. Journal of Cancer Survivorship 8(2): 183-189, 2015

Treatment for asymptomatic anthracycline-induced cardiac dysfunction in childhood cancer survivors: the need for evidence. Journal of Clinical Oncology 21(17): 3377; Author Reply 3377-8, 2003

Low-dose dobutamine stress test for the evaluation of cardiac function using ultrafast computed tomography. Clinical Cardiology. 16(6): 473-479, 1993

Low-dose dobutamine stress test for the evaluation of cardiac function using ECG-gated SPECT scintigraphy with 99mTc-MIBI. Kaku Igaku. Japanese Journal of Nuclear Medicine 32(1): 75-79, 1995

Evaluation of cardiotoxicity by tissue Doppler imaging in childhood leukemia survivors treated with low-dose anthracycline. Pediatric Cardiology 36(4): 862-866, 2015

Assessing anthracycline-treated childhood cancer survivors with advanced stress echocardiography. Pediatric Blood and Cancer 62(3): 502-508, 2015

Noninvasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors. Journal of Clinical Oncology 25(24): 3635-3643, 2007

LV structure, LV function, and serum NT-proBNP in childhood cancer survivors without anthracycline or cardiac radiation exposures. Progress in Pediatric Cardiology 31(2): 141-142, 2011